Aligned Genetics Inc Total Liabilities

Latest as of September 2025: ₩9.61 Billion KRW ≈ $6.51 Million USD

Aligned Genetics Inc total liabilities. Based on the latest financial reports, Aligned Genetics Inc (238120) has total liabilities worth ₩9.61 Billion KRW (≈ $6.51 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Aligned Genetics Inc liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Aligned Genetics Inc (2015–2024)

Total liabilities of Aligned Genetics Inc from 2015 to 2024. This chart illustrates how Aligned Genetics Inc's total liabilities have evolved over time, based on quarterly financial data. Explore Aligned Genetics Inc (238120) investment intensity to see how much of total assets are deployed in long-term investments.

Aligned Genetics Inc Competitors by Total Liabilities

The table below lists competitors of Aligned Genetics Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Myungmoon Phar KO:017180	Korea	₩168.00 Billion
Boundless Bio, Inc. Common Stock NASDAQ:BOLD	USA	$58.55 Million
Pamapol S.A. WAR:PMP	Poland	zł500.62 Million
Blaize Holdings, Inc. NASDAQ:BZAI	USA	$59.60 Million
Ovaro Kiinteistosijoitus Oyj HE:OVARO	Finland	€32.18 Million
Latrobe Magnesium Limited F:L2Q	Germany	€43.84 Million
Archtis Ltd AU:AR9	Australia	AU$15.84 Million
PESTECH International Bhd KLSE:5219	Malaysia	RM1.27 Billion

Liability Composition Analysis (2015–2024)

This chart breaks down Aligned Genetics Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 238120 asset base.

Liquidity & Leverage Metrics

Aligned Genetics Inc Total Liabilities Ratios Explained

Aligned Genetics Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	10.05	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.27	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.21	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Aligned Genetics Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Aligned Genetics Inc (2015–2024)

The table below shows the annual total liabilities of Aligned Genetics Inc from 2015 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩8.78 Billion ≈ $5.95 Million	-8.73%
2023-12-31	₩9.62 Billion ≈ $6.52 Million	+19.48%
2022-12-31	₩8.05 Billion ≈ $5.46 Million	+7.68%
2021-12-31	₩7.48 Billion ≈ $5.07 Million	+86.12%
2020-12-31	₩4.02 Billion ≈ $2.72 Million	+9.99%
2019-12-31	₩3.65 Billion ≈ $2.48 Million	+72.88%
2018-12-31	₩2.11 Billion ≈ $1.43 Million	+26.75%
2017-12-31	₩1.67 Billion ≈ $1.13 Million	-0.67%
2016-12-31	₩1.68 Billion ≈ $1.14 Million	+110.80%
2015-12-31	₩796.04 Million ≈ $539.46K	--

About Aligned Genetics Inc

KQ:238120 Korea Medical Devices

Market Cap

$25.63 Million

₩37.82 Billion KRW

Market Cap Rank

#24117 Global

#1698 in Korea

Share Price

₩2690.00

Change (1 day)

+2.28%

52-Week Range

₩2435.00 - ₩6050.00

All Time High

₩7875.00